Clinical trial
The Effect of Goal-directed Fluid Therapy on Postoperative Complications in Patients Undergoing Laparoscopic Hepatobiliary or Pancreatic Surgery
NCT03169998 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Goal-directed Fluid Therapy on Postoperative Complications in Patients Undergoing Laparoscopic Hepatobiliary or Pancreatic Surgery
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- December 31, 2021
- Enrollment
- 375 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver diseases, pancreas disease